Company: PFSA
Filing Date: 2025-04-03
Form Type: S-4/A
Source: 0001213900-25-028544
Chunk: 349

Company: Profusa, Inc.
Filing Date: 2025-04-03
Form: S-4/A
Chunk 349
---
centive Equity Value is expected to be $29,018,330 for purposes of this proxy statement/prospectus. The outstanding principal balance of the Profusa Senior Secured Convertible Promissory Notes and all accrued but unpaid interest will convert into Profusa Common Stock and NorthView will exchange the Profusa Common Stock for 4,660,000shares of New Profusa, an as converted price of $0.50 per share. We refer you to tickmark (U) in the pro forma presentation below, which reflects the cash receipt and issuance of convertible debt, through to the settlement of the convertible debt and issuance of additional paid in capital (APIC) common stock for these shares. The current balance of the Profusa Senior Secured Convertible Promissory Notes is $2.2million as of this filing. $0.9million and 4,660,000 New Profusa Shares are included in the pro forma, which is based on the current balance and anticipated investor contributions prior to close. Additionally, we refer you to tickmarks (FF) in the pro forma Income Statement presentation below, to reflect the 12% interest being accrued on this loan through settlement. •NorthView’s Convertible Working Capital loan will be converted at close of the Business Combination. Current balance of the note is $1,919,796, which has been fair value adjusted on the balance sheet as of December31, 2024 to $8,908,052, and which is included in the pro forma at the current balance as no interest accrues on this note and will be converted into 863,908shares of New Profusa, an as converted price of $2.22 per share. We refer you to tickmark (R) in the pro forma presentation below, which reflects the cash receipt and issuance of shares upon conversion of the convertible debt. •Profusa entered into a Binding Term Sheet for APAC Joint Venture. If Profusa and Tasly establish the JV, Profusa will grant the JV an exclusive license to its intellectual property to use, develop, manufacture and commercialize the Licensed Products in the Asia Pacific region. In connection with the license, Tasly would pay Profusa $6 million (of which $1.6 million has been received through the date of this proxy statement/prospectus) to purchase 60% of the share capital of the JV from Profusa, and the JV would pay Profusa 5% royalties on sales, and 30% royalties on income from royalties, sub